Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Franklin India Flexi Cap Fund |
|---|---|
| 01 Jan 2013 | ₹100.00 |
| 20 Feb 2014 | ₹103.23 |
| 11 Apr 2015 | ₹182.76 |
| 30 May 2016 | ₹184.90 |
| 19 Jul 2017 | ₹229.80 |
| 07 Sep 2018 | ₹257.45 |
| 27 Oct 2019 | ₹237.10 |
| 14 Dec 2020 | ₹285.57 |
| 02 Feb 2022 | ₹425.49 |
| 24 Mar 2023 | ₹409.50 |
| 12 May 2024 | ₹619.17 |
| 01 Jul 2025 | ₹732.93 |
| 20 Aug 2026 | ₹717.33 |
| Metric | Franklin Templeton · Direct NAV ₹1,819.80 Very High risk ★★★☆☆ | Category median Flexi Cap Fund · 46 funds |
|---|---|---|
| -0.53% | +4.32% | |
| +13.66% | +14.11% | |
| +14.07% | +12.53% | |
| +13.73% | +13.78% | |
| +15.55% | +14.48% | |
| +11.86% | — | |
| +16.71% | +16.56% | |
| +15.91% | +15.80% | |
| +16.12% | +15.46% | |
| Risk | ||
| 13.43% | 14.19% | |
| 0.53 | 0.53 | |
| 0.73 | 0.73 | |
| -37.72% | -30.01% | |
| Nifty 500 | — | |
| +1.78% | +2.15% | |
| 0.91 | 0.97 | |
| 99.3% | 102.4% | |
| 89.2% | 90.2% | |
| 0.99% | 0.96% | |
| ₹18,941Cr | ₹4,325Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 7% | 34% | |
| R Janakiraman · 13.6y | — | |
| 01 Jan 2013 | — | |
| 57 | — | |
| 42.0% | — | |
| 4.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.